Group items tagged

MaRS Client, Axela, talks about moving from human protein testing into the agricultural markets -- the challenges and the opportunities.

MaRS tenant Axela Inc. pursues South American diagnostic assay market through MOU with Cria Opportunities Inc.

CML HealthCare Inc is planning to automate it's current infrastructure to deliver greater volume and medical laboratory tests. CML is also working to commercialize early-stage technologies in medical diagnostics in partnership with an Ontario government agency known as MaRS Innovation.

Toronto is a globally competitive centre for groundbreaking basic and clinical research, with historical and current strengths in areas including new cancer therapeutics, stem cell research and development, genomics, bioinformatics, and the development of new diagnostic and therapeutic tools for every imaginable disease process.

Operating out of Toronto's MaRS Discovery Centre, Arctic DX's seven employees take existing research on genetic markers and develop diagnostic tests for disease.

Great Industry Canada source for Innovation, Research, and Science and Technology commercialization. Links to Information Resources, Diagnostic Tools, Industry Associations, Financing, laws, and other services are provided.

Linda Ko blogs about The Business of Aging Summit which was jointly organized by Toronto's innovation incubator, the MaRS Centre, and the Ontario government. This event plans to showcase the work of 14 up-and-coming Ontario companies now developing software, diagnostic tools and other technologies aimed specifically at the aging population. Dec 1, 2009

The week of October 3, 2011,  Segasist Technologies, a MaRS client and tenant will launch its' new cancer diagnostic tool Reconcillio at the American Society for Radiation Oncology conference. Reconcillio is Segasist Technologies' third product and is awaiting FDA approvals.

Created by the International Business Center at Michigan State University, globalEDGE is a knowledge web-portal that connects professionals worldwide to global business activities. The site offers: * Global Resources - more than 5,000 online resources * Country Insights - a wealth of information on all countries * Industry Profiles - in-depth analysis of selected industries * News & Views - latest issues in international business * Academy - extensive research and teaching resources * Diagnostic Tools - decision-support tools for managers * globalEDGE Network - connect with 33,399 registered users globalEdge offers a wide range of information and knowledge. Partnership opportunities are also available for international growth of businesses.

CML HealthCare Inc is planning to automate it's current infrastructure to deliver greater volume and medical laboratory tests. CML is also working to commercialize early-stage technologies in medical diagnostics in partnership with an Ontario government agency known as MaRS Innovation.

This round of financing builds on a $2.2 million seed round raised in 2010, led by MaRS Innovation.

The Ontario Genomics Institute has given funding to MaRS life sciences client, ArcticDX. They'll use the money for studies in preparation for a Food and Drug Administration approval for their product. The funding comes through its Pre-Commercialization Business Development Fund (PBDF)

As stated in the Toronto Staf, according to Kain, Director at the centre for Travel and Tropical Medicine at Toronto General Hospital, "Toronto officials should study travelers and the illnesses the bring back to understand and cope with widespread outbreaks of diseases."

As stated in the Toronto Star, according to Kain, Director at the centre for Travel and Tropical Medicine at Toronto General Hospital, "Toronto officials should study travelers and the illnesses the bring back to understand and cope with widespread outbreaks of diseases." Nov 11, 2005

Claron Technologies develops and provides imaging processing solutions for the medical imaging industry. Claron Technologies outlines how MaRS Discovery District has helped them to reach their success.

Islam D, Zhang N, Wang P, Li H, Brubaker PL, Gaisano HY, Wang Q, Jin T. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines. The research lab is located in teh MaRS Centre.

Islam D, Zhang N, Wang P, Li H, Brubaker PL, Gaisano HY, Wang Q, Jin T. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines. The research lab is located in teh MaRS Centre. March 4, 2009

Research from P.B. Stathopulos and colleagues has provided new data on biological chemistry.

Research from P.B. Stathopulos and colleagues has provided new data on biological chemistry. March 6, 2009

BNN talks to Niall Wallace, CEO, Infonaut Inc. about their invention of mapping out infectious diseases. Brief mention about MaRS.

Kalgene Diagnostics and Precision Therapeutics receive funding from ParteQ Innovations

Four Kingston startup companies receive $1.6 million vote of confidence PARTEQ venture fund's investments help to advance discoveries in pharmaceutical, biomedical and alternative energy sectors. Kalgene, a MaRS client, has received investment from the PARTEQ Venture Fund.